Use of Proton Pump Inhibitors Among Patients With Alcohol‐Related Cirrhosis—A Danish Nationwide Cohort Study
The use of PPIs continues to be prevalent among patients with ALD cirrhosis, with 40% of all patients using PPIs in 2022. Within the first 3 months after diagnosis, 38% of all patients were using PPIs. Our results provide essential background information for future RCTs on the risks and benefits of prescribing or deprescribing PPIs.
Authors
- Marine Sølling Ramsing (ORCID: https://orcid.org/0000-0002-8174-7928)
- Peter Jepsen (ORCID: https://orcid.org/0000-0002-6641-1430)
- Morten Daniel Jensen (ORCID: https://orcid.org/0000-0002-5137-7268)
Institutions
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Liver International
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1111/liv.70061
- Citations
- 2
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Novo Nordisk Fonden